Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CERUS CORP Director's Dealing 2012

Nov 16, 2012

33349_dirs_2012-11-16_3a4ca1e4-66c6-4094-87d1-04a91d947d07.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CERUS CORP (CERS)
CIK: 0001020214
Period of Report: 2012-11-16

Reporting Person: CORASH LAURENCE M (Director, Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-16 Common Stock P 2000 $2.849 Acquired 574200 Direct